Gentris opens biomarker shop in Shanghai

Morrisville, NC-based Gentris is setting up a new genomic biomarker testing service in Shanghai, a growing global hub for drug development. "Gentris is creating an international quality, global organization capable of providing genomic biomarker testing and biobanking services for clinical trials," said CEO Amelia Wall Warner. "In addition to commercial services, we are building collaborations with top Chinese research organizations, universities, and companies to accelerate drug development and innovation." Release | More

Suggested Articles

Qiagen launched a one-stop shop compiling publicly available genomic data, scientific literature and phenotypic information on potential superbugs.

Adaptive Biotechnologies is planning a $200 million IPO to help power its sequencing tests aimed at the body’s immune system and related therapies.

Abbott’s new diabetes test provides A1c results in three minutes, allowing clinicians to develop care plans within a single office visit.